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Kathryn B. Garber1,*Diagnosis of 25% of Cases Referred for Whole-Exome
Sequencing
In the New England Journal of Medicine, the clinical diag-
nostic laboratories from Baylor College of Medicine report
their results from the first 250 patients referred for clinical
exome sequencing; most of these patients were children
with neurologic conditions. Of the whole group, 25%
ended up with a molecular diagnosis for their referring
phenotype, a success rate thatheld true in thenext500cases
and that rivals the success rate for chromosomemicroarray
in individuals with neurodevelopmental disorders. Con-
trary to rules of parsimony, four of the probands actually
had two independent genetic conditions that together
explained their overall phenotype. For a significant number
of the total group of patients, pathogenic mutations
occurred in genes that were linked to a disease only within
the past 2 years, so little is known about them. More recog-
nizable syndromeswerepresent inotherpatients, including
four cases within the Noonan syndrome spectrum.
Yang et al. (2013). N. Engl. J. Med. 369, 1502–1511.
Ready or Not, Here They Come
Within the genetics community, we can argue about the
incidentalome and reportable variants all we want, but
many physicians outside of the specialty have little under-
standing of the promise or pitfalls of genomic medicine.
Readyornot, patientsmight soonbring their genome infor-
mation to their physicians. A recent exome sequence study
fromGonzalez-Garay et al. gives us a senseofwhat to expect
when this test is performed without a specific diagnostic
purpose. It’s one thing to sort through a set of data like
this to try to find the one change that best explains a certain
trait, as described in the Yang et al. study above; it’s another
altogether to extract all of the potentially meaningful
information from each sequence. The authors’ process for
selecting reportable variants filters the variants on the basis
of frequency, their predicted effect on theprotein, and com-
parisons with the Human GenomeMutation Database and
OnlineMendelian Inheritance inMan—pretty standard ap-
proaches. One advantage they had that is often lacking in
genetic testingwas that each of the 81 adult volunteers pro-
vided thorough medical and family histories to be used in
the analysis. In several cases, the specific history could be
matched with a genetic variant in the patient. In other
cases, they uncovered autosomal-dominant risk alleles
that were expected to predispose the volunteer to cancer,1Department of Human Genetics, Emory University School of Medicine, Atlan
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cautionary note on these predictions, three men in their
sample carried X-linked variants that were predicted to be
disease causing, although none of the three was affected
with the relevant disorder. The critical need for genomics
education of nonspecialist physicians is clear from the
fact that nearly three-quarters of the volunteers reported
bringing their results to their primary care physician for
further discussion.
Gonzalez-Garay et al. (2013). Proc. Natl. Acad. Sci. USA
110, 16957–16962.
Give Us a Hand
One of several things that set humans apart from apes is
our population bias toward right-handedness. Although
handedness seems to have substantial heritability, little
headway has been made in uncovering the causative ge-
netic variation. Brandler et al. previously found a genetic
association between handedness and a SNP in PCSK6,
which encodes a protease that regulates NODAL; in turn,
NODAL determines left-right asymmetry. In a recent study
in PLoS Genetics, this research group assessed the larger role
of patterning genes in handedness. They used a pathway-
based approach to genetic association with handedness
and found an overrepresentation of variation in genes
that cause asymmetry phenotypes when disrupted in
mice. They argued that handedness might be a complex
trait governed by the same mechanisms that establish
asymmetry during development.
Brandler et al. (2013). PLoS Genet. 9, e1003751.
Transgenerational Effect of Mutation Affecting Folate
Metabolism
Folate is important for proper fetal development—that’s
why we fortify our food supply with folic acid. Although
we understand that folate carries methyl groups that
are needed for a variety of biochemical reactions, our
understanding of the mechanisms by which folate influ-
ences development is incomplete. Padmanabhan et al.
were interested in this problem and made a mouse with a
hypomorphic allele in the gene encoding methionine
synthase reductase, Mtrr, an important enzyme in the
folate pathway. When they started crossing heterozygotes
for this allele, the pups were present in Mendelian ratios,
but litter sizes were somewhat smaller than normal.
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and found that many had congenital malformations or
developmental delay but that these defects occurred inde-
pendently of the genotype of the pup. The defects seemed
to be occurring through an epigenetic effect rather than a
genetic effect. Through a careful series of controlled crosses
and embryo transfers, the authors were able to establish
that these defects were due to the Mtrr genotype of the
maternal grandparents and that the Mtrr deficiency leads
to epigenetic instability associated with altered gene
expression in the placenta of the grandprogeny, even if
they are wild-type. The presence of these congenital de-
fects persists over several generations.
Padmanabhan et al. (2013). Cell 155, 81–93.778 The American Journal of Human Genetics 93, 777–778, NovembMendelian Variation and Complex Traits
Interested in the genetic underpinnings of complex dis-
ease, Blair et al. were intrigued by reports that patients
with certain rare Mendelian conditions are at an increased
risk of unrelated complex conditions. To explore this
further, they mined the medical records of millions of peo-
ple to look for comorbid Mendelian and complex diseases,
and they found thousands of these associations. Further
analyses related to this comorbidity allowed them to
develop a model for certain complex diseases in which
combinations of Mendelian variants contribute nonaddi-
tively to their risk.
Blair et al. (2013). Cell 155, 70–80.This Month in Our Sister JournalsDealing with Uncertainty and Error
With the advent of next-generation sequencing tech-
nologies, the dramatic decrease in the costs of DNA
sequencing means that researchers can sequence many
more individuals for a similar cost. Theoretically, this
should provide better population genetic data. Parti-
cularly with low-coverage sequencing data, though,
sequence errors and uncertain genotype calls are a prob-
lem and can produce biased allele-frequency distribu-tions. Fumagalli circumvented the issues with next-gener-
ation sequence data through a Bayesian approach that
takes genotype uncertainty into account and allows the
estimation of Fst without the need to call specific geno-
types. Another approach that they developed for assess-
ing population structure uses principal-component anal-
ysis and avoids genotype calling.
Fumagalli et al. (2013). Genetics. Published online August
26, 2013. http://dx.doi.org/10.1534/genetics.113.154740.er 7, 2013
